Data access enablement Subsalt provides certified de-identified clinical data compliant with HIPAA Expert Determination, addressing a critical bottleneck in healthcare research, external collaboration, and AI initiatives. This creates a compelling value proposition for health systems seeking faster, compliant data access for innovation.

AI research acceleration By removing traditional governance and IRB review delays, Subsalt positions itself as a speed-enhancing layer for researchers and AI developers who require timely access to real-world clinical data.

Strategic partnerships The platform’s ability to generate safe data copies is attractive for academic institutions, pharma, and health tech firms looking to run pilot studies, collaborations, or co-development projects with reduced compliance risk.

Secure runtime expansion Recent launch of Secure Runtime signals an expansion of capabilities for analyzing protected health data, presenting cross-sell opportunities to current users and appeal to enterprises seeking end-to-end secure analytics pipelines.

Growth potential With revenue in the low to mid single digits and a lean team, Subsalt appears primed for targeted enterprise outreach to larger health systems and research networks seeking scalable data access solutions, suggesting a scalable upsell path as adoption grows.